San Mateo, CA, United States of America

Jerry Wroblewski

USPTO Granted Patents = 3 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2015-2022

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Jerry Wroblewski: Innovator in Otic Formulations

Introduction

Jerry Wroblewski is a notable inventor based in San Mateo, California. He has made significant contributions to the field of otic formulations, holding a total of three patents. His work focuses on the development of innovative methods and compositions for administering ciprofloxacin, a widely used antibiotic.

Latest Patents

Wroblewski's latest patents include a ciprofloxacin otic composition and kits for its administration. The disclosed otic product kits are designed for the administration of a sterilized formulation. These kits typically comprise an aseptic container containing the sterilized formulation, a syringe, and an administration needle connectable to the syringe. The sterilized formulation includes multiparticulate ciprofloxacin, poloxamer 407, and water. Additionally, he has developed methods for preparing and administering this sterilized formulation, which involve transferring the formulation from an aseptic container to a syringe and injecting it into the ear of a patient. Another significant patent involves methods for sterilizing ciprofloxacin compositions, which include forming an aqueous suspension of ciprofloxacin particles, heating it, and allowing it to cool down. These methods aim to provide sustained release of ciprofloxacin for treating various otic disorders.

Career Highlights

Throughout his career, Wroblewski has worked with prominent companies in the pharmaceutical industry, including Otonomy, Inc. and Alk-Abello, Inc. His expertise in otic formulations has positioned him as a key player in the development of innovative treatments for ear-related conditions.

Collaborations

Wroblewski has collaborated with notable professionals in his field, including Scott H. Coleman and Wei-Cheng Liaw. These collaborations have contributed to the advancement of his research and the successful development of his patented technologies.

Conclusion

Jerry Wroblewski's contributions to the field of otic formulations demonstrate his commitment to innovation and improving patient care. His patents reflect a deep understanding of pharmaceutical science and a dedication to developing effective treatments for otic disorders.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…